American multinational biopharmaceutical company
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock: Eli Lilly's stock growth from its obesity drug faces competition, while Amgen's undervalued ...
seekingalpha.com/article/4681374-move-over-eli-lilly-amgen-could-be-the-next-obesity-wonder-stock
Paid articlePaid
Amgen: I Prefer To Chase Value And Dividends: Amgen is executing well with sales and volume growth, and has a robust development pipeline ...
seekingalpha.com/article/4683764-amgen-i-prefer-to-chase-value-and-dividends
Paid articlePaid Amgen: The Giant With An Impressive Pipeline: Amgen's acquisition of Horizon Therapeutics transforms it into a leader in rare disease treatments ...
seekingalpha.com/article/4683743-amgen-the-giant-with-an-impressive-pipeline
Paid articlePaid
Obesity-drug power duo Novo Nordisk and Eli Lilly have room to run, analysts say: BMO analysts cut price target for Amgen, another contender in the weight-loss ...
marketwatch.com/story/obesity-drug-power-couple-novo-nordisk-and-eli-lilly-still-have-room-to-run-analysts-say-c37743b9
Manager of long/short mutual fund touts Amgen: Joseph Artuso of Easterly Investment Partners knows how to hedge a portfolio.
charlotteobserver.com/news/business/article287459920.html
A Novo Nordisk competitor teased a weight loss drug that minimizes muscle loss seen in other drugs
qz.com/altimmune-muscle-weight-loss-1851370538
Paid articlePaid
Enbrel drugmaker sues over Colorado’s potential price cap, says prescription drug board is unconstitutional
denverpost.com/2024/03/26/amgen-sues-colorado-prescription-drug-affordability-board-enbrel-price-cap/
Amgen quarterly profit rises 15%, obesity drug trials are on track: Amgen (AMGN.O) on Tuesday said its adjusted fourth-quarter profit rose 15% ...
reuters.com/business/healthcare-pharmaceuticals/amgen-quarterly-profit-rises-15-horizon-deal-boosts-results-2024-02-06/
Quick Glance: Netanyahu Rejects Hamas Ceasefire, Pursues Total Victory
- Netanyahu says total victory in Gaza is within reach, rejecting the latest offer from Hamas for a ceasefire to ensure the return of hostages.
- He renews a pledge to destroy the Palestinian Islamist movement, insisting that total victory is the only solution to the Gaza war.
- Hamas had proposed a ceasefire of four-and-a-half months, during which all hostages would go free and Israel would withdraw its troops from the Gaza Strip.
- A Hamas delegation would travel to Cairo on Thursday to pursue ceasefire talks with the mediators Egypt and Qatar.
Amgen quarterly profit rises 15%, obesity drug trials are on track: Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase ...
reut.rs/3HRMKJ4
Colorado Is Trying to Cap a Drug’s Price. Big Pharma Has Other Plans: After a state board declared Enbrel “unaffordable,” some lawmakers want to exempt large ...
rollingstone.com/politics/politics-features/colorado-drug-price-enbrel-pharma-1234977554/
Amgen taking different path to weight loss windfall: The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to ...
reuters.com/business/healthcare-pharmaceuticals/amgen-taking-different-path-weight-loss-windfall-2024-02-06/
High flyer Novo Nordisk - these companies are ready for the chase: Novo Nordisk leads obesity treatment market, followed by Eli Lilly, while Roche ...
deraktionaer.de/artikel/deraktionaerplus/ueberflieger-novo-nordisk-diese-unternehmen-sind-startklar-zur-verfolgungsjagd--20351377.html
Drugmakers plot way into obesity market with deals and development: Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative ...
reut.rs/3S207eG
Bloomberg Markets - Bloomberg: Bloomberg delivers business and markets news, data, analysis, and video to the world, featuring stories from Businessweek and ...
bloomberg.com/markets
US FDA revises labeling on Amgen's drug to treat bone loss: The U.S. health regulator said on Friday it has revised the prescribing information on Amgen's drug ...
reut.rs/48FoYM6
Tango Therapeutics Must Produce Its Own Data To Justify Its Valuation: Tango Therapeutics stock experienced a significant increase after positive data from ...
seekingalpha.com/article/4661515-tango-therapeutics-must-produce-own-data-to-justify-valuation
Paid articlePaid
3 Dividend Stocks for December 2023: The dividend prospects for three firms with economic moats.
morningstar.com/stocks/3-dividend-stocks-december-2023-2
No global carbon price? Some companies set their own: A growing list of global companies are setting a price or charging themselves for each metric ton of their ...
thedailystar.net/business/global-economy/news/no-global-carbon-price-some-companies-set-their-own-3491631
US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision: Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the U ...
reuters.com/markets/deals/us-senator-elizabeth-warren-expresses-disappointment-ftcs-amgen-decision-2023-11-09/
Investment bankers see dealmaking lull storing pent-up demand: Some of the world's top investment bankers said on Wednesday that a drop in corporate dealmaking ...
reuters.com/markets/deals/reuters-next-investment-bankers-see-dealmaking-lull-storing-pent-up-demand-2023-11-08/
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug: The U.S. Food and Drug Administration on Tuesday approved Amgen's (AMGN ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-amgens-biosimilar-vesrion-jjs-stelara-2023-10-31/
Amgen sales rise, but shares off as investors await obesity data: Amgen (AMGN.O) on Tuesday said third-quarter sales rose 5%, but a full-year sales forecast ...
reuters.com/business/healthcare-pharmaceuticals/amgen-third-quarter-sales-rise-5-profit-up-before-charge-2023-10-31/
$AMGN - Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript). seekingalpha.com/article/4654937-amgen-inc-amgn-presents-6th-annual-evercore-isi-healthconx-conference-transcript?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated #stocks #finance #stockmarket
Everything is lining up right for these stocks, according to Piper Sandler: These stocks can benefit from a convergence of key factors, Piper Sandler says
cnbc.com/2023/11/03/everything-is-lining-up-right-for-these-stocks-according-to-piper-sandler.html
Paid articlePaid
Amgen to cut 350 Horizon jobs across Ireland and the US: Company announced plans last year to expand operations in Waterford
irishexaminer.com/business/companies/arid-41255320.html
US FDA panel says Amgen lung cancer drug data cannot be relied on: Advisers to the U.S. Food and Drug Administration on Thursday found that data from a ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-gives-thumbs-down-approval-amgen-lung-cancer-drug-2023-10-05/
Drugmakers sign on to negotiate Medicare prices under protest: All the drugmakers that make the 10 prescription medicines subject to the first-ever price ...
reuters.com/business/healthcare-pharmaceuticals/drugmakers-sign-negotiate-medicare-prices-under-protest-2023-10-02/
Sanofi Makes Progress on Skin Drug in Boost for New Growth Areas: Sanofi’s experimental skin medicine produced better results after a longer treatment ...
bloomberg.com/news/articles/2023-10-13/sanofi-makes-progress-on-skin-drug-in-boost-for-new-growth-areas
Amgen completes $27.8 billion Horizon deal: Amgen (AMGN.O) said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics (HZNP ...
reuters.com/markets/deals/amgen-completes-278-bln-horizon-deal-2023-10-06/
Amgen's late-stage data for lung cancer drug 'not adequate' - FDA staff: The U.S. Food and Drug Administration staff reviewers said on Tuesday Amgen's (AMGN ...
reuters.com/business/healthcare-pharmaceuticals/fda-staff-says-late-stage-data-not-enough-amgens-lung-cancer-drug-2023-10-03/
Insight: Big Pharma bets on AI to speed up clinical trials: Major drugmakers are using artificial intelligence to find patients for clinical trials quickly ...
reuters.com/technology/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22/
SoftBank-backed Neumora seeks $2.74 bln valuation in US IPO: Neumora Therapeutics, backed by Amgen (AMGN.O) and Japan's SoftBank (9984.T) ...
reuters.com/markets/deals/softbank-backed-neumora-therapeutics-aims-raise-up-2648-mln-us-ipo-2023-09-11/
SoftBank-backed Neumora valued at $2.51 billion in lukewarm debut: Shares of Neumora Therapeutics (NMRA.O), which is backed by Amgen (AMGN.O) and Japan's ...
reuters.com/markets/deals/softbank-backed-neumora-bags-251-billion-valuation-lackluster-debut-2023-09-15/
Amgen’s plans for €1bn Waterford campus in doubt: The US biotech giant says it will evaluate options following completion of €26 billion takeover of Horizon
businesspost.ie/news/amgens-plans-for-e1bn-waterford-campus-in-doubt/
Paid articlePaid Analysis: FTC settlement could shelter Amgen from US price cuts, taxes: The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of ...
reuters.com/business/healthcare-pharmaceuticals/ftc-settlement-could-shelter-amgen-us-price-cuts-taxes-2023-09-05/
FTC, Amgen reach deal to allow $28 billion pharmaceutical merger: The Federal Trade Commission dropped its lawsuit to block Amgen’s merger with Horizon ...
washingtonpost.com/business/2023/09/01/amgen-horizon-ftc-lawsuit/
Tomorrow's front page. Pick up a copy in stores or subscribe at businesspost.ie :
🗞️ Coalition targets floating SF voters in budget
🗞️ Revenue uses ESB data in vacant ... Show more
Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise: Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) ...
reuters.com/markets/deals/nvidia-amgen-back-ai-driven-drug-firm-generatebiomedicines-273-mln-fundraise-2023-09-14/
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
reuters.com/markets/deals/us-ftc-suspends-challenge-block-amgens-278-bln-deal-horizon-therapeutics-2023-08-26/
Here are Wednesday's biggest analyst calls: Nvidia, Apple, Tesla, Nio, SoFi, Amgen, Chewy, Toast & more
cnbc.com/2023/09/06/wednesdays-biggest-wall-street-calls-like-nvidia-apple.html
Paid articlePaid
Morningstar Reveals These Punished Value Stocks Are Now Leading the Quality Rally
boerse-online.de/nachrichten/aktien/morningstar-verraet-diese-abgestraften-value-aktien-fuehren-jetzt-die-qualitaets-rallye-an-20338406.html
SoftBank-backed Neumora Therapeutics files paperwork for U.S. IPO: Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen (AMGN ...
reuters.com/markets/deals/softbank-backed-neumora-therapeutics-files-paperwork-us-ipo-2023-08-25/
Horizon Therapeutics (HZNP) Jumps On A New #FTC Development In The Amgen Takeover Battle
investors.com/news/technology/hznp-stock-jumps-on-a-new-ftc-development-in-the-amgen-takeover-battle/
The Federal Trade Commission has given its approval for Amgen's ambitious $27.8 billion purchase of Horizon Therapeutics.
@esha_hanspal tells you more
Watch ... Show more wionews.com/videos
VIRICA Index: Evergreen: Five big players from the pharmaceutical and biotech industries drive up the VIRICA Index. With an investment ...
deraktionaer.de/artikel/pharma-biotech/virica-index-dauerbrenner-20338694.html
Paid articlePaid
Gilead inks deal with biologics developer Tentarix co-founded by BC entrepreneurs
theglobeandmail.com/business/article-gilead-inks-deal-with-biologics-developer-tentarix-co-founded-by-bc/
Paid articlePaid Closing bell: MercadoLibre and Disney turn up the heat, monster deal burdens Tapestry
deraktionaer.de/artikel/indizes/schlussglocke-mercadolibre-und-disney-drehen-auf-monster-deal-belastet-tapestry-20337493.html
Lightning update: US indices deep red, pharma and biotech outliers: The US stock exchanges experience the expected rough start to trading on Tuesday: Dow Jones ...
deraktionaer.de/artikel/indizes/blitz-update-us-indizes-tiefrot-pharma-und-biotech-als-ausreisser-20337281.html
Markets in the morning: Apple, Amgen, Siemens Energy, Siemens, Commerzbank, CTS, SMA Solar, UniCredit
California, other states join FTC bid to block Amgen deal: The states of California, New York, Illinois, Minnesota, Washington and Wisconsin have joined a ...
reuters.com/markets/deals/california-other-states-join-ftc-bid-block-amgen-deal-2023-06-22/
UnitedHealth unit to add Boehringer's Humira biosimilar to reimbursement list: Boehringer Ingelheim's biosimilar of AbbVie Inc's (ABBV.N) blockbuster arthritis ...
reuters.com/business/healthcare-pharmaceuticals/unitedhealth-unit-add-boehringers-humira-biosimilar-reimbursement-list-2023-06-23/
Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast
reuters.com/business/healthcare-pharmaceuticals/stelara-patent-deal-puts-jj-back-path-57-bln-2025-revenue-forecast-2023-06-05/
vitality in the region - Many Germans do not know their cholesterol level - and thus take a high risk
vital-region.de/news/viele-deutsche-kennen-ihren-cholesterinwert-nicht-und-gehen-so-ein-hohes-risiko-ein/
Coherus BioSciences to launch Humira biosimilar at 85% discount: Coherus BioSciences Inc (CHRS.O) said on Thursday it plans to launch a biosimilar of AbbVie ...
reuters.com/business/healthcare-pharmaceuticals/coherus-biosciences-launch-humira-biosimilar-995-per-carton-2023-06-01/
FTC sues to stop drugmaker Amgen from completing $27.8 billion deal: The Federal Trade Commission is seeking to block Amgen's $27.8 billion deal to acquire ...
washingtonpost.com/business/2023/05/16/ftc-lawsuit-amgen-pharmaceutical-deal/
A more aggressive FTC is starting to target drug mergers and industry middlemen: An FTC lawsuit against the Amgen-Horizon merger raises issues about PBMs’ role ...
usatoday.com/story/news/health/2023/05/21/ftc-targets-amgen-horizon-drug-mergers-pbms/70237166007/
Paid articlePaid Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara: Johnson & Johnson (JNJ.N) has settled its lawsuit over Amgen Inc's (AMGN ...
reuters.com/business/healthcare-pharmaceuticals/amgen-settles-jj-patent-lawsuit-over-drug-similar-blockbuster-stelara-2023-05-23/
Amgen agrees not to seek quick close to Horizon acquisition: Amgen Inc (AMGN.O) has agreed not to quickly close on its $27.8 billion acquisition of Horizon ...
reuters.com/legal/us-court-issues-temporary-restraining-order-278-bln-amgen-horizon-deal-2023-05-18/
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears: Investors are scrambling to assess the fallout of a U.S. regulatory challenge against ...
reuters.com/markets/deals/amgens-antitrust-woes-spur-wider-pharmaceutical-deal-fears-2023-05-17/
Why The Biotech Buying Bonanza Will Likely Continue: Big Pharma has a problem, and buying up biotech stocks helps solve it. But the FTC has gripes about M&A ...
investors.com/news/technology/biotech-stocks-are-in-blistering-ma-climate-ftc-could-change-that/
Wall Street closes lower after Home Depot outlook, US retail sales: U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and ...
reuters.com/markets/us/futures-flat-ahead-debt-ceiling-talks-data-2023-05-16/
Quick Glance: Home Depot Reports Biggest Revenue Miss in 20 Years, Lowers Forecast Due to Delays in Big Projects
- Cold weather and falling lumber prices hurt sales in the fiscal first quarter.
- Home Depot expects a decline of 2% to 5% in sales and comparable sales for the fiscal year.
- According to CFO Richard McPhail, Home Depot anticipates a period of moderation in 2023, following Americans' huge interest in home improvement projects during the Covid pandemic.
- Home Depot missed Wall Street's revenue expectations for the second quarter in a row. Last quarter was the first time the company fell short of analysts' expectations since November 2019, before the pandemic.
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents: The U.S. Supreme Court on Thursday ruled against Amgen Inc (AMGN ...
reuters.com/legal/us-supreme-court-rules-against-amgen-bid-revive-cholesterol-drug-patents-2023-05-18/
Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs: Reportedly, Novartis which is also named in this complaint is preparing to spin ...
financialexpress.com/healthcare/pharma-healthcare/amgen-sues-sandoz-to-block-generic-version-of-bone-cancer-and-osteoporosis-drugs/3072497/
Jailed Dutch-Chinese scientist 'forgotten' by his country and company: Dr Zhang Mingqiang is in cell number 204 of Shanghai’s notorious Qingpu prison – sentenced ...
rfi.fr/en/international/20230526-jailed-dutch-chinese-scientist-forgotten-by-his-country-and-company
High drug prices: Horizon sale on the brink: Amgen's nearly $28 billion purchase of Horizon Therapeutics is on the brink. If the transaction fails ...
nzz.ch/wirtschaft/die-us-kartellbehoerde-zeigt-ihre-zaehne-milliardenschwere-akquisitionen-werden-fuer-pharmafirmen-schwieriger-ld.1738768
Vincent Boland: US regulator’s shot across bows of Amgen/Horizon deal leaves big pharma reeling
businesspost.ie/article/vincent-boland-us-regulators-shot-across-bows-of-amgen-horizon-deal-leaves-big-pharma-reeling/
A global antitrust alliance battles Microsoft and Amgen: The UK and US are emerging as the toughest enforcers of limits on technology takeovers
ft.com/content/5ebd3c7c-56f9-4ee2-a8f1-3cc8955c227b
Paid articlePaid
Guess how much big pharma paid in US taxes on $110 billion of profit in 2022: Pfizer, Merck, J&J, Gilead, Eli Lilly, Amgen BMS, and AbbVie paid a combined $2 ...
qz.com/guess-how-much-big-pharma-paid-in-us-taxes-on-110-bill-1850441135
Paid articlePaidNew to NewsWall?
Sign up now to get your own personalized news!
Trending topics